Inari Medical Inc.

NASDAQ: NARI · Real-Time Price · USD
79.97
0.00 (0.00%)
At close: Feb 18, 2025, 3:59 PM

Inari Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
493.63M 383.47M 276.98M
Cost of Revenue
59.07M 44.51M 24.76M
Gross Profit
434.56M 338.96M 252.23M
Operating Income
-14.03M -28.1M 6.67M
Interest Income
15.61M 1.85M 154K
Pretax Income
4.25M -26.18M 10.69M
Net Income
-1.64M -29.27M 9.84M
Selling & General & Admin
350.66M 292.84M 190.37M
Research & Development
87.53M 74.22M 51.02M
Other Expenses
n/a 356K -18K
Operating Expenses
448.6M 367.06M 241.38M
Interest Expense
196K 294K 295K
Selling & Marketing Expenses
1.2M 957K 344K
Cost & Expenses
507.66M 411.57M 266.14M
Income Tax Expense
5.88M 3.08M 845K
Shares Outstanding (Basic)
56.77M 52.84M 49.82M
Shares Outstanding (Diluted)
56.77M 52.84M 55.59M
EPS (Basic)
-0.03 -0.55 0.20
EPS (Diluted)
-0.03 -0.55 0.18
EBITDA
15.19M -18.25M 15.51M
EBIT
4.44M -25.89M 10.98M
Depreciation & Amortization
10.73M 7.64M 4.53M